Results 51 to 60 of about 435,985 (290)

Effects of Moderate Alcohol Drinking in Patients with Nonalcoholic Fatty Liver Disease

open access: yesGut and Liver, 2019
Whether moderate alcohol intake is beneficial remains an unsolved issue. Recent studies have suggested that moderate alcohol consumption is associated with beneficial effects related to the prevention of cardiovascular diseases.
Inbeom Kwon, Dae Won Jun, Jin-Hwa Moon
doaj   +1 more source

Prevalence of alcohol-related pathologies at autopsy: Estonian Forensic Study of Alcohol and Premature Death. [PDF]

open access: yes, 2014
AIMS: Alcohol can induce diverse serious pathologies, yet this complexity may be obscured when alcohol-related deaths are classified according to a single underlying cause.
Helander, Anders   +8 more
core   +1 more source

Collaborative care for alcohol-related liver disease [PDF]

open access: yesClinical Medicine, 2007
By implementing collaborative care for patients with alcohol misuse and alcohol-related liver disease, the Royal Bolton Hospital aimed to improve and coordinate their care by recruiting a multidisciplinary team and placing the patient at the centre of all efforts.
Kieran J, Moriarty   +10 more
openaire   +2 more sources

Alcohol-related mortality in deprived UK cities: worrying trends in young women challenge recent national downward trends [PDF]

open access: yes, 2013
Background: Glasgow, the largest city in Scotland, has high levels of deprivation and a poor-health profile compared with other parts of Europe, which cannot be fully explained by the high levels of deprivation.
Shipton, Deborah   +2 more
core   +1 more source

Transitioning from NAFLD to MAFLD and MASLD: the toxic relationship with alcohol consumption [PDF]

open access: yesExploration of Medicine
Alcohol is a well-known toxic etiologic factor for liver injury. Metabolic substrates of alcohol (especially acetaldehyde) have a major responsibility and genetic susceptibility, alterations in microbiota and immune system are important co-factors for ...
Mubin Ozercan   +2 more
doaj   +1 more source

Primary Alcohol-Activated Human and Mouse Hepatic Stellate Cells Share Similarities in Gene-Expression Profiles. [PDF]

open access: yes, 2020
Alcoholic liver disease (ALD) is a leading cause of cirrhosis in the United States, which is characterized by extensive deposition of extracellular matrix proteins and formation of a fibrous scar.
Baglieri, Jacopo   +16 more
core   +1 more source

Outpatient management of alcohol-related liver disease

open access: yesThe Lancet Gastroenterology & Hepatology, 2020
Alcohol-related liver disease has become the leading indication for liver transplantation in the USA, partly due to an increase in the prevalence of high-risk drinking behaviour and alcohol use disorder, particularly among young women. Achieving sustained alcohol abstinence might not only prevent the development and progression of alcohol-related liver
Douglas A, Simonetto   +2 more
openaire   +3 more sources

Dimethyl fumarate combined with cisplatin at subcytotoxic doses sensitizes cervical cancer toward ferroptosis and apoptosis through GSH restriction and p53 (re)activation

open access: yesMolecular Oncology, EarlyView.
Dimethyl fumarate (DMF) reduces growth of HPV‐positive cervical cancer spheroids and induces ferroptosis in cervical cancer cells via blocking SLC7A11/Glutathione (GSH) axis. Combination of subcytotoxic doses of DMF and cisplatin (CDDP) further suppresses spheroid growth and drives cell death in 2D culture models.
Carolina Punziano   +6 more
wiley   +1 more source

Alcohol consumption and the risk of liver disease: a nationwide, population-based study

open access: yesFrontiers in Medicine, 2023
IntroductionAlthough most patients with alcohol-related liver disease (ALD) have a history of prolonged and heavy drinking, there is no clear threshold defining the level of alcohol consumption that leads to ALD.
Sang Yi Moon   +5 more
doaj   +1 more source

Intestinal fungi contribute to development of alcoholic liver disease [PDF]

open access: yes, 2017
This study was supported in part by NIH grants R01 AA020703, U01 AA021856 and by Award Number I01BX002213 from the Biomedical Laboratory Research & Development Service of the VA Office of Research and Development (to B.S.). K.H.
Ali Keshavarzian   +37 more
core   +3 more sources

Home - About - Disclaimer - Privacy